Effect of Somatostatin and Octreotide on Proliferation and Vascular Endothelial Growth Factor Secretion from Murine Endothelial Cell Line (HECa10) Culture
- 16 February 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 268 (2), 567-571
- https://doi.org/10.1006/bbrc.2000.2119
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Octreotide and Nonendocrine Tumors: Basic Knowledge and Therapeutic PotentialPublished by S. Karger AG ,2015
- Somatostatin (SRIF) stimulates the release of interleukin-6 (IL-6) from human peripheral blood monocytes (PBM) in vitroNeuropeptides, 1995
- Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial.Journal of Clinical Oncology, 1995
- Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreasCancer, 1995
- Sensitivity and specificity of the manning criteriaGastroenterology, 1992
- Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.Proceedings of the National Academy of Sciences, 1992
- The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of TumorsEndocrine Reviews, 1991
- Somatostatin suppression of meningioma cell proliferationin vitroActa Neurologica Scandinavica, 1987
- SomatostatinNew England Journal of Medicine, 1983
- SomatostatinNew England Journal of Medicine, 1983